Application of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphoma

Saved in:
Bibliographic Details
Main Authors: Mihaljević Biljana, Janković Snežana, Jaković Ljubomir, Jovanović-Peruničić Maja, Anđelić Boško, Milošević Violeta, Sretenović Aleksandra, Virijević Marjana, Petrović Milan
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2008-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2008/0042-84500803229M.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849698789359616000
author Mihaljević Biljana
Janković Snežana
Jaković Ljubomir
Jovanović-Peruničić Maja
Anđelić Boško
Milošević Violeta
Sretenović Aleksandra
Virijević Marjana
Petrović Milan
author_facet Mihaljević Biljana
Janković Snežana
Jaković Ljubomir
Jovanović-Peruničić Maja
Anđelić Boško
Milošević Violeta
Sretenović Aleksandra
Virijević Marjana
Petrović Milan
author_sort Mihaljević Biljana
collection DOAJ
format Article
id doaj-art-a80201cb7d4d438b856484bf304802ad
institution DOAJ
issn 0042-8450
language English
publishDate 2008-01-01
publisher Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
record_format Article
series Vojnosanitetski Pregled
spelling doaj-art-a80201cb7d4d438b856484bf304802ad2025-08-20T03:18:49ZengMinistry of Defence of the Republic of Serbia, University of Defence, BelgradeVojnosanitetski Pregled0042-84502008-01-0165322923310.2298/VSP0803229MApplication of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphomaMihaljević BiljanaJanković SnežanaJaković LjubomirJovanović-Peruničić MajaAnđelić BoškoMilošević VioletaSretenović AleksandraVirijević MarjanaPetrović Milanhttp://www.doiserbia.nb.rs/img/doi/0042-8450/2008/0042-84500803229M.pdflymphomanon-Hodgkinantibodiesmonoclonaldrug therapydrug therapycombinationantineoplastic combined chemotherapy protocols
spellingShingle Mihaljević Biljana
Janković Snežana
Jaković Ljubomir
Jovanović-Peruničić Maja
Anđelić Boško
Milošević Violeta
Sretenović Aleksandra
Virijević Marjana
Petrović Milan
Application of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphoma
Vojnosanitetski Pregled
lymphoma
non-Hodgkin
antibodies
monoclonal
drug therapy
drug therapy
combination
antineoplastic combined chemotherapy protocols
title Application of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphoma
title_full Application of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphoma
title_fullStr Application of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphoma
title_full_unstemmed Application of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphoma
title_short Application of monoclonal anti-CD20 antibody rituximab in the treatment of non-Hodgkin's lymphoma
title_sort application of monoclonal anti cd20 antibody rituximab in the treatment of non hodgkin s lymphoma
topic lymphoma
non-Hodgkin
antibodies
monoclonal
drug therapy
drug therapy
combination
antineoplastic combined chemotherapy protocols
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2008/0042-84500803229M.pdf
work_keys_str_mv AT mihaljevicbiljana applicationofmonoclonalanticd20antibodyrituximabinthetreatmentofnonhodgkinslymphoma
AT jankovicsnezana applicationofmonoclonalanticd20antibodyrituximabinthetreatmentofnonhodgkinslymphoma
AT jakovicljubomir applicationofmonoclonalanticd20antibodyrituximabinthetreatmentofnonhodgkinslymphoma
AT jovanovicperunicicmaja applicationofmonoclonalanticd20antibodyrituximabinthetreatmentofnonhodgkinslymphoma
AT anđelicbosko applicationofmonoclonalanticd20antibodyrituximabinthetreatmentofnonhodgkinslymphoma
AT milosevicvioleta applicationofmonoclonalanticd20antibodyrituximabinthetreatmentofnonhodgkinslymphoma
AT sretenovicaleksandra applicationofmonoclonalanticd20antibodyrituximabinthetreatmentofnonhodgkinslymphoma
AT virijevicmarjana applicationofmonoclonalanticd20antibodyrituximabinthetreatmentofnonhodgkinslymphoma
AT petrovicmilan applicationofmonoclonalanticd20antibodyrituximabinthetreatmentofnonhodgkinslymphoma